Mono Pharmacare Ltd

Mono Pharmacare Ltd

₹ 23.8 -0.42%
02 May 9:56 a.m.
About

Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]

Key Points

Business Overview:[1]
MPL is a distributor and supplier of a wide array of pharmaceutical products and medicines. It offers
Health Care Products, Antibiotic medicines, Cough Cold Anti-Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid
& Antiemetic medicines, Cardiac – Diabetic medicines, and Cosmo care products.

  • Market Cap 42.0 Cr.
  • Current Price 23.8
  • High / Low 47.2 / 22.1
  • Stock P/E 14.6
  • Book Value 17.2
  • Dividend Yield 0.00 %
  • ROCE 10.3 %
  • ROE 11.8 %
  • Face Value 10.0

Pros

  • Debtor days have improved from 195 to 94.2 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Sep 2023 Mar 2024 Sep 2024
35 67 56 87
33 63 53 82
Operating Profit 2 4 2 5
OPM % 6% 6% 4% 5%
0 0 0 0
Interest 1 2 2 2
Depreciation 0 0 0 0
Profit before tax 1 2 1 3
Tax % 39% 20% 33% 27%
1 2 1 2
EPS in Rs 0.52 1.06 0.33 1.30
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 TTM
27 122 143
25 116 136
Operating Profit 2 6 7
OPM % 6% 5% 5%
0 0 0
Interest 1 3 3
Depreciation 0 0 0
Profit before tax 1 3 4
Tax % 25% 24%
1 2 3
EPS in Rs 0.57 1.38 1.63
Dividend Payout % 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 41%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -47%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Sep 2024
Equity Capital 12 18 18
Reserves 1 10 13
40 41 49
9 12 20
Total Liabilities 63 81 100
1 1 1
CWIP 0 0 0
Investments 1 0 0
61 80 99
Total Assets 63 81 100

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
-28 -9
-1 0
30 8
Net Cash Flow 0 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
Debtor Days 296 94
Inventory Days 497 139
Days Payable 103 32
Cash Conversion Cycle 689 202
Working Capital Days 703 204
ROCE % 10%

Shareholding Pattern

Numbers in percentages

5 Recently
Sep 2023Dec 2023Mar 2024Sep 2024Mar 2025
56.72% 56.72% 56.72% 56.72% 56.72%
43.28% 43.27% 43.28% 43.28% 43.28%
No. of Shareholders 621528418463478

Documents